NCT06390579

Brief Summary

The research team, recognized as a world leader in Artificial Intelligence for neuro-ophthalmology, has shown that it is possible to diagnose certain neuro-ophthalmologic or neurologic disorders from a single retinal fundus image (Milea et al, New England Journal of Medicine, 2020). However, clinical practice requires identifying a broader spectrum of diseases (inflammatory, ischemic, hereditary, neurodegenerative) within the same analysis. The main objective is to develop, through a new algorithm capable of classifying multiple disorders from a smaller set of conventional retinal images. This project meets a significant public health need: the global shortage of neuro-ophthalmologists. It aims to provide healthcare professionals with a rapid triage tool to detect serious and treatable conditions, enabling timely intervention. The study will include patients with clearly defined neuro-ophthalmologic or neurologic conditions, confirmed diagnoses, and retinal imaging. Clinical, paraclinical, and imaging data collected during standard care will be used, with strict anonymization according to legal and institutional requirements. Specific Objectives :

  1. 1.Evaluate the performance of a diagnostic classification algorithm trained on retinal images.
  2. 2.Assess the ability to detect multiple pathologies from a single retinal image.
  3. 3.Support the development of advanced computer vision tools for medical diagnostics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
693

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

April 25, 2024

Last Update Submit

September 1, 2025

Conditions

Keywords

fundus imagingautomated diagnosismulti-class classificationclinical decision support

Outcome Measures

Primary Outcomes (1)

  • Diagnostic performance of the Artificial Intelligence algorithm in detecting multiple neuro-ophthalmologic and neurologic conditions from retinal imaging.

    Evaluation of the algorithm's sensitivity, specificity, and area under the receiver operating caracteristics curve for classifying multiple neuro-ophthalmologic and neurologic pathologies using retinal fundus photography and Optical Coherence Tomography images, compared with expert-established reference diagnoses.

    baseline

Interventions

Deep learning algorithm applied on retrospectively collected color fundus photographs

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Color fundus photographs taken within 30 days from the date of onset

You may qualify if:

  • Patients with well-defined neuro-ophthalmologic or neurologic conditions, including different forms of optic neuropathies and various neurodegenerative diseases.
  • Patients with a robust reference diagnosis confirmed by clinical experts.
  • Patients with available retinal fundus images collected during routine care.

You may not qualify if:

  • Patients without a confirmed diagnosis or unclear clinical classification.
  • Patients without retinal fundus images or with images that are completely unreadable.
  • Patients whose data cannot be anonymized according to legal and institutional protocols.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Fondation Adolphe de Rothschild

Paris, France, 75019, France

Location

Related Publications (1)

  • Gungor A, Sarbout I, Gilbert AL, Hamann S, Lebranchu P, Hobeanu C, Gohier P, Vignal-Clermont C, Dumitrascu OM, Cohen SY, Lagreze WA, Feltgen N, van der Heide F, Lamirel C, Jonas JB, Obadia M, Racoceanu D, Milea D. Artificial Intelligence-Based Detection of Central Retinal Artery Occlusion Within 4.5 Hours on Standard Fundus Photographs. J Am Heart Assoc. 2025 Jul;14(13):e041441. doi: 10.1161/JAHA.124.041441. Epub 2025 Jun 27.

MeSH Terms

Conditions

Optic Nerve DiseasesOptic Neuropathy, IschemicOptic NeuritisPapilledemaOptic AtrophyBrain Neoplasms

Condition Hierarchy (Ancestors)

Cranial Nerve DiseasesNervous System DiseasesEye DiseasesVascular DiseasesCardiovascular DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2024

First Posted

April 30, 2024

Study Start

October 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations